Company Filing History:
Years Active: 2018-2023
Title: **Innovative Contributions of Christopher Francklyn**
Introduction
Christopher Francklyn, based in Burlington, VT, is a prominent inventor with significant contributions to the field of biotechnology. With a total of six patents to his name, Francklyn has focused on advancing methods for diagnosing diseases associated with threonyl-tRNA synthetase, showcasing his commitment to medical innovation.
Latest Patents
Francklyn's latest patent involves "Methods and compounds for diagnosing threonyl-tRNA synthetase-associated diseases and conditions." This innovative invention encompasses methods and compounds aimed at diagnosing diseases characterized by altered threonyl-tRNA synthetase (TARS) activity, particularly conditions where angiogenesis is affected. The patent details a process in which the level of a TARS molecule is measured and compared to a control level, allowing for the assessment of disease onset, progression, and regression related to TARS activity.
Career Highlights
Christopher Francklyn is affiliated with the University of Vermont and State Agricultural College, where he continues to explore the intersections of biochemistry and medicine. His work not only contributes to the scientific community but also has a tangible impact on understanding and treating complex diseases.
Collaborations
Throughout his career, Francklyn has collaborated with distinguished colleagues, including Karen M. Lounsbury and Tamara Williams. Their joint efforts exemplify the collaborative spirit of research and development, yielding patents that push the boundaries of current medical diagnostics.
Conclusion
Christopher Francklyn's innovative work in the field of biotechnology, particularly through his patents on threonyl-tRNA synthetase-associated diseases, marks him as a significant figure in modern biomedical research. His ongoing contributions and collaborations reflect a dedication to improving diagnostics and treatment outcomes for patients, underscoring the vital role of inventors in advancing healthcare solutions.